B.C.'s Applied Biologicals Commercializes R&D With Government Support
Applied Biological Materials Inc. of British Columbia has succeeded in commercializing a new detection system for genetic information.
Location Canada 2011
The company has developed a microRNA (miRNA) expression and detection system where miRNA is known to regulate the genome, which is the basic foundation for human health and medical conditions. The system is used in life science research and biotechnology industries across Canada and the world.
"Research in miRNA holds great promise for the life science community and can ultimately contribute to innovative diagnostic assays and therapeutic modalities. Through government of Canada support, Applied Biological Materials Inc. has been elevated to become one of the world's top players in this technology," said CEO Dr. Peter Li. "Our dominant position has opened and will continue to open new job opportunities in Canada. In short, it is almost impossible for Applied Biological Materials Inc. to take on cutting-edge research and development, like the miRNA project, without the government's support."
Project Announcements
Minth Group Plans Windsor, Ontario, Canada, Manufacturing Operations
04/07/2025
Siemens Canada Expands Oakville, Ontario, Operations
04/03/2025
Crust Craft Expands Edmonton, Alberta, Canada, Production Operations
03/27/2025
Frontier Lithium Plans Thunder Bay, Ontario, Canada, Chemical Production Operations
03/10/2025
Linamar Corporation Expands Ontario, Canada, Production Operations
02/03/2025
NEO Battery Materials Plans Windsor, Ontario, Canada, Silicon Anode Operations
01/28/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025